Literature DB >> 7623389

An intensive outpatient approach for cocaine abuse treatment. The Matrix model.

R A Rawson1, S J Shoptaw, J L Obert, M J McCann, A L Hasson, P J Marinelli-Casey, P R Brethen, W Ling.   

Abstract

The Matrix model of outpatient treatment was developed during the 1980s in response to an overwhelming demand for cocaine abuse treatment services. The model was constructed using components based upon empirically supported findings from the substance abuse research field. Over the course of development, data were collected on the treatment model and the model was modified based upon empirical evaluation. A pilot study comparing the Matrix outpatient model with an inpatient hospital treatment program produced preliminary support for the clinical utility of the model. An open trial comparing publicly and privately funded patients demonstrated that patients with fewer resources were more difficult to engage and retain in this model of outpatient treatment. In a controlled trial, a clear positive relationship was documented between duration and amount of treatment involvement in the Matrix model and positive outcome at 1 year. Due to a variety of methodological issues, the study was not able to answer definitively the question of clinical efficacy. In all of these studies, patients treated with the Matrix model demonstrated statistically significant reductions in drug and alcohol use and improvements in psychological indicators. This body of work, along with the public acceptance the model has received in the treatment community, support the usefulness of this intensive outpatient approach for cocaine abuse. Further research is underway to provide additional controlled information on the value of this treatment approach.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7623389     DOI: 10.1016/0740-5472(94)00080-b

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  48 in total

1.  Development of an evidence-based, gay-specific cognitive behavioral therapy intervention for methamphetamine-abusing gay and bisexual men.

Authors:  Cathy J Reback; Steven Shoptaw
Journal:  Addict Behav       Date:  2011-11-26       Impact factor: 3.913

Review 2.  Choosing a behavioral therapy platform for pharmacotherapy of substance users.

Authors:  Kathleen M Carroll; Thomas R Kosten; Bruce J Rounsaville
Journal:  Drug Alcohol Depend       Date:  2004-08-16       Impact factor: 4.492

3.  Developing an evidence-based, multimedia group counseling curriculum toolkit.

Authors:  Adam C Brooks; Graham Diguiseppi; Alexandre Laudet; Beth Rosenwasser; Dan Knoblach; Carolyn M Carpenedo; Deni Carise; Kimberly C Kirby
Journal:  J Subst Abuse Treat       Date:  2012-02-01

4.  Treating depression and substance use: a randomized controlled trial.

Authors:  Sarah B Hunter; Katherine E Watkins; Kimberly A Hepner; Susan M Paddock; Brett A Ewing; Karen C Osilla; Suzanne Perry
Journal:  J Subst Abuse Treat       Date:  2012-02-01

5.  Strategies to encourage adoption in multisite clinical trials.

Authors:  Joseph Guydish; Barbara Tajima; Sarah Turcotte Manser; Martha Jessup
Journal:  J Subst Abuse Treat       Date:  2006-11-22

6.  Randomized clinical trial evaluating the preliminary effectiveness of an integrated anxiety disorder treatment in substance use disorder specialty clinics.

Authors:  Kate Wolitzky-Taylor; Jennifer Krull; Richard Rawson; Peter Roy-Byrne; Richard Ries; Michelle G Craske
Journal:  J Consult Clin Psychol       Date:  2018-01

7.  Multi-level assessment protocol (MAP) for adoption in multi-site clinical trials.

Authors:  J Guydish; S T Manser; M Jessup; B Tajima; C Sears; T Montini
Journal:  J Drug Issues       Date:  2005-07-01

8.  Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.

Authors:  Ann L Anderson; Shou-Hua Li; Denka Markova; Tyson H Holmes; Nora Chiang; Roberta Kahn; Jan Campbell; Daniel L Dickerson; Gantt P Galloway; William Haning; John D Roache; Christopher Stock; Ahmed M Elkashef
Journal:  Drug Alcohol Depend       Date:  2015-02-07       Impact factor: 4.492

9.  Ecological momentary assessments for self-monitoring and counseling to optimize methamphetamine treatment and sexual risk reduction outcomes among gay and bisexual men.

Authors:  Cathy J Reback; Dennis Rünger; Jesse B Fletcher; Dallas Swendeman
Journal:  J Subst Abuse Treat       Date:  2018-06-15

10.  Beyond methamphetamine: Documenting the implementation of the Matrix model of substance use treatment for opioid users in a South African setting.

Authors:  Jessica F Magidson; Hetta Gouse; Warren Burnhams; Christie Y Y Wu; Bronwyn Myers; John A Joska; Adam W Carrico
Journal:  Addict Behav       Date:  2016-11-17       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.